Epigenomics Signs Distribution Deal with Pronto Diagnostics for Epi proColon in Israel
Epigenomics expands commercial reach for CE-marked product beyond home market
18-Oct-2010 -
Epigenomics AG and Pronto Diagnostics Ltd. announced that they have signed an exclusive distributor agreement for the commercialization of Epigenomics’ Epi proColon test in Israel.
Epi proColon is the world’s first CE-marked molecular diagnostic test for the early detection of colorectal cancer ...
blood tests
colorectal cancer
Diagnostic test
+2